Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04074096
Title Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis (BEPCOME-MB)
Acronym BEPCOME-MB
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
APHP - Hôpital Avicenne Bobigny France Details
CHU de Bordeaux - Hôpital Saint André Bordeaux France Details
GH Sud CHU Bordeaux - Hôpital Levêque Bordeaux France Details
APHP - Hôpital Ambroise Paré Boulogne-Billancourt France Details
CHU de Caen Caen France Details
CLCC - Centre Jean François Baclesse Caen France Details
APHP - Hôpital Henri Mondor Créteil France Details
CHU de Dijon - Hopital Du Bocage Dijon France Details
CLCC - Centre Georges François Leclerc Dijon France Details
CLCC - Centre Léon Bérard Lyon France Details
APHM - Hopital De La Timone Marseille France Details
CHU De Montpellier - Hopital Saint Eloi Montpellier France Details
CLCC - Institut de Cancerologie de Montpellier Montpellier France Details
CHU Nice - Hôpital de l'Archet Nice France Details
CLCC - Centre Antoine Lacassagne Nice France Details
APHP - L'hôpital de la Pitié-Salpêtrière Paris France Details
CHU de Nantes - Hôtel Dieu Saint-Herblain France Details
CLCC - Institut de Cancerologie de l'Ouest - Nantes Saint-Herblain France Details
CLCC - IUCT-0 / Institut Claudius Regaud Toulouse France Details
CHU de TOURS - Hôpital Bretonneau Tours France Details
CLCC - Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field